Antigen Detection Kit with Blocking Strand for False Positive Removal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing immunoassays face challenges with false positive signals due to non-specific binding of detection antibodies, leading to inaccurate antigen detection, especially when the antigen amount is small, which can result in significant errors during viral antigen detection.

Innovation Solution

A kit and method utilizing a substrate with a capture antibody and a detection antibody labeled with fluorescent materials, along with a blocking strand that prevents complementary binding between the capture and detection strands, allowing for accurate antigen detection by removing false positive signals through fluorescence measurement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If a detection antibody is used to bind to the antigen, then the antigen can be detected, but false positive signals occur due to non-specific binding to other sites such as the substrate surface

Engineering Contradiction:
Improveantigen detection accuracyVSAvoidsignal specificity
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

A blocking antibody is introduced as an intermediary component that specifically binds to the detection antibody, preventing it from non-specifically binding to the substrate surface. The blocking antibody acts as a mediator that allows specific antigen detection while blocking false positive signals, thereby resolving the contradiction between detection accuracy and signal specificity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If the detection sensitivity is increased to detect small amounts of antigen, then diagnostic accuracy improves, but false positive signals become more significant and cause big errors

Engineering Contradiction:
Improvedetection sensitivityVSAvoiddiagnostic accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The blocking antibody serves as a mediator that enables high detection sensitivity while maintaining diagnostic accuracy. By specifically blocking non-specific binding sites on the detection antibody, it allows the detection of small antigen amounts without being overwhelmed by false positive signals, thus resolving the contradiction between sensitivity and reliability.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If a large amount of blood is collected to ensure sufficient antigen for detection, then detection reliability improves, but the burden on the subject increases

Engineering Contradiction:
Improvedetection reliabilityVSAvoidblood collection burden
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The invention changes the parameter of detection sensitivity by introducing the blocking antibody system, which enables reliable antigen detection from smaller blood volumes. The blocking antibody eliminates false positive signals that would otherwise require larger sample volumes to overcome, thereby reducing the blood collection burden while maintaining detection reliability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution significantly reduces false positive signals, enhancing the sensitivity and accuracy of antigen detection, particularly for small antigen amounts, thereby improving diagnostic accuracy and reducing the burden of blood collection.

Implementation Method 1

a capture antibody attachable onto the substrate and having a capture strand labeled with a fluorescent material; a detection antibody having a detection strand labeled with a fluorescent material

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

a blocking strand having a base sequence capable of complementary binding to the capture strand or the detection strand to prevent the detection strand and the capture strand from complementary binding to each other

Methodology Applied
Scientific EffectComplementary binding: Chemical Bonding

Data Source

PatentUS12259382B2Antigen detection method and kit with false positive signal removed
Publication Date: 2025.03.25 JL MEDILABS INC
  • US12259382B2 patent drawing
  • US12259382B2 patent drawing
  • US12259382B2 patent drawing

AI summary

A kit for detecting an antigen from which false positive signals are removed is provided. The kit includes a substrate; a capture antibody attachable onto the substrate and having a capture strand labeled with a fluorescent material; a detection antibody having a detection strand labeled with a fluorescent material and complementary to some or all of a base sequence of the capture strand; and a blocking strand having a base sequence capable of complementary binding to the capture strand or the detection strand to prevent the detection strand and the capture strand from complementary binding to each other.